Khetha Ikhasi

Iyini ukuhlolwa kwe-antibody ye-HCV?

Ukuhlolwa kwe-antibody ye-HCV kusetshenziselwa ukuxilonga ukutheleleka kwegciwane le-hepatitis C. Ukuhlolwa kwegazi okuhlonza ama-antibodies e-hepatitis C egazini. Lapho umzimba utheleleka ngegciwane le-hepatitis C, umzimba uzokhiqiza ama-antibodies okulwa nokutheleleka kwegciwane. Ukuhlolwa kwe-HCV kuhlonza la ma-antibodies egazini. Lokhu kuhlolwa kunconywa emaqenjini asengozini enkulu, okuhlanganisa abasebenzisi bezidakamizwa, abasebenzi bezempilo, kanye nezingane zomama abane-HCV. Lokhu kuhlolwa kunconywa futhi uma unezimpawu ezifana nokucanuzela kwenhliziyo, ukukhathala, umchamo omnyama, uhudo, i-jaundice, kanye nokuncipha kwesifiso sokudla njengoba i-HCV ithelela isibindi.

Udinga Usizo Lwezokwelapha?

Khuluma Nochwepheshe Bethu Bezempilo!

isithombe sikadokotela

Udinga Usizo Lwezokwelapha?

Unemibuzo?

Kungani Kufanele Ukhethe Izibhedlela zaseYashoda

Izibhedlela zaseYashoda zizibophezele ekuhlinzekeni ukwelashwa okusezingeni lomhlaba kweziguli ezivela emhlabeni wonke. Ngenhlanganisela eyingqayizivele yobuchwepheshe besimanje, ukunakekelwa okunembile, kanye nokugqwesa kwezokwelapha, siyindawo yokunakekelwa kwempilo yezinkulungwane zeziguli zamazwe ngamazwe eNdiya.

Kungenalutho
Ukunakekelwa Okuphelele

Ohambweni oluya empilweni enhle, siyaqonda ukuthi kubalulekile ukuthi uzizwe usekhaya. Sihlela zonke izici zohambo lwakho.

Kungenalutho
Odokotela Abangongoti

Ochwepheshe abanolwazi benza ukuhlinzwa okungahlaseli futhi okungahlaseli kakhulu ukuze banikeze ukwelashwa okungcono kakhulu kweziguli zakwamanye amazwe.

Kungenalutho
Ukusika-Edge Technology

Izibhedlela zethu zihlonyiswe ngobuchwepheshe obuthuthukisiwe bokwenza izinqubo eziningi kanye nokwelashwa.

Kungenalutho
Ubuhle Bomtholampilo

Sihlinzeka ngokugqwesa ngokuhlinzeka ngezinsizakalo zezempilo ezisheshayo nezisebenzayo nangocwaningo oluphambili olusiza zonke iziguli zethu zesikhathi esizayo.

imibuzo ejwayelekile ukubuzwa

Ukuhlolwa kwe-antibody ye-HCV kusetshenziselwa ukuhlonza ukuchayeka kwangaphambilini noma ukutheleleka kwamanje ngegciwane le-hepatitis C. Lokhu kuhlolwa kuhlonza amasosha omzimba egciwane le-hepatitis C, ngakho-ke akunakusiza ekuhlukaniseni phakathi kokutheleleka okusebenzayo kwegciwane kanye nokutheleleka kwangaphambilini. Ngezinye izikhathi, umphumela ongalungile unikezwa ekuhlolweni okubuthakathaka okuhle.

Imiphumela yokuhlolwa ebonisa ama-antibodies e-HCV angasasebenzi ikhombisa ukuthi awekho ama-antibodies e-HCV egazini. Laba ziguli abanazo izifo ze-HCV zamanje noma zangaphambilini. Ukuhlolwa kwe-antibody ye-HCV okusabela kubonisa ukutheleleka okucatshangelwayo kwe-HCV. Ukuhlolwa kwe-HCV RNA kungaphakanyiswa ngemuva kokuhlolwa kwe-antibody ye-HCV ukuze kutholakale ukuthi isiguli esinjalo sike saba nesifo muva nje.

Kuphakanyiswa ukuthi wonke umuntu oseqenjini leminyaka eli-18 kuya kwengama-79 kufanele ahlolwe ngokuhlolwa kwe-antibody ye-HCV. Abanye abantu abaguli ngenxa yokutheleleka ngegciwane le-hepatitis C, kodwa kuyalimaza isibindi sabo kancane kancane. Ukwenza ukuhlolwa kungavimbela nokusabalala kwaleli gciwane. Uma ungoweqembu eliyingozi njengesisebenzi sezempilo noma umsebenzisi wezidakamizwa ongekho emthethweni, kufanele wenze lokhu kuhlolwa.

Ukuhlolwa kwe-antibody ye-HCV ukuhlolwa kwegazi okusetshenziselwa ukuhlola ukutheleleka kwe-hepatitis C. Ukuhlolwa kuthola ama-antibodies e-HCV egazini ngosizo lwe-Enzyme Immunoassay. Imiphumela yokuhlolwa ibonakala njengemihle neyimbi, okubonisa ukutheleleka kwegciwane le-hepatitis C okwedlule noma kwamanje emzimbeni.

I-antibody ye-HCV enhle isho ukuthi umuntu utheleleke ngegciwane le-hepatitis C. Lokhu kutheleleka kungaba nganoma yisiphi isikhathi empilweni yakhe. Ukutheleleka kwe-HCV kubangela ukwakheka kwama-antibodies ngokumelene negciwane le-hepatitis C emzimbeni. Lawa ma-antibodies azohlala egazini futhi abonakala ngalolu vivinyo.

Uhla olujwayelekile lwe-HCV "alutholakali" njengoba lubonisa ukuthi awukaze utheleleke ngaleli gciwane. Uhla oluningi lokuhlolwa kwe-antibody ye-HCV luyi-10–100,000,000 IU/mL (1.0 - 8.0 log IU/mL). Ucwaningo lukhombisile ukuthi ukuhlolwa kunganikeza imiphumela engalungile cishe ku-10% wamasampula.

Ama-antibodies e-HCV akhiwa njengendlela yokulwa negciwane le-hepatitis C emzimbeni. Lawa ma-antibodies ahlala emzimbeni impilo yonke futhi awanyamalali. Kodwa-ke, ngaphansi kweziguli eziyi-15%, la ma-antibodies ayanyamalala ngokuzenzekelayo. Ukususwa kwala ma-antibodies akubonisi ukusekelwa kokutheleleka emzimbeni.

Ama-antibodies e-HCV akhiqizwa ukuphendula ukutheleleka futhi ahlala egazini kuze kube phakade. Kodwa-ke, la ma-antibodies e-HCV kubantu awavikeli umzimba ekuthelelekeni ngegciwane le-hepatitis C. Indlela yokuvikela umzimba kuleli gciwane iqondiswa amaseli e-CD4 kanye ne-CD8 T. Lawa maseli asiza ekuhlinzekeni ngokuzivikela okuzivumelanisa nezimo kumuntu ngamunye.

Ama-antibodies e-HCV akhiwa njengendlela yokulwa nokutheleleka kwe-HCV. Lawa ma-antibodies angahlala egazini iminyaka engama-20. Lawa ma-antibodies ahlala emazingeni atholakalayo ngisho nangemva kokuncipha kwezimpawu zomtholampilo. Kanye nalawa ma-antibodies, i-antigen kanye negciwane nakho kuhlala emzimbeni emazingeni aphansi uma kuqhathaniswa.

Uma umphumela wokuhlolwa ungewona owamasosha omzimba i-HCV, ama-antibodies e-HCV awatholakali egazini futhi umuntu akanayo i-HCV. Uma umphumela wokuhlolwa ungowamasosha omzimba i-HCV, kubonisa ukutheleleka kwe-HCV okucatshangelwayo. Kulezi zimo, kwenziwa ukuhlolwa kwe-HCV RNA ukuze kutholakale izinkinga ezisebenzayo nezamanje zokutheleleka kwe-HCV.

Bhukha i-aphoyintimenti, thola umbono wesibili wamahhala.

Bhuka i-aphoyintimenti
kumaminithi we-2